Health Care/Hospital APAC News & Press Release Distribution

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia

Note: This press release, with MLR code: MPR-ID-100139, supersedes the version issued on 18/01/2024, 11:00. * Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadershi...

2024-01-19 13:15 1418

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

GUANGZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Infinitus kicked off 2024 with the 'Co-creating a New Future' annual conference held in Foshan,Guangdong on January 13, 2024. Family members of the Lee Kum Kee Group and Infinitus’ Central Management ...

2024-01-19 11:42 1749

Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong

Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program

Double Collaboration Agreement Signing Marks a Milestone at Sheraton Petaling Jaya Hotel KUALA LUMPUR, Malaysia, Jan. 19, 2024 /PRNewswire/ -- The Airai State Government welcomes Airai Global Corporation in a historic collaboration to revolutionize eco-tourism and healthcare inPalau. This transf...

2024-01-19 10:00 1772

Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:34 1797

Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance

SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...

2024-01-18 22:18 1821

PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (...

2024-01-18 16:00 2217

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific

* Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year inAsia Pacific * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development...

2024-01-18 12:00 1493

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Thailand

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inThailand * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development BANGKO...

2024-01-18 12:00 1296

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Malaysia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inMalaysia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development KUALA ...

2024-01-18 12:00 1302

Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia

* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development JAK...

2024-01-18 12:00 1339

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

* Octapharma will present new clinical and scientific findings for wilate® and Nuwiq® * New findings in von Willebrand disease (VWD) and haemophilia A, will be presented by leading experts in a Satellite Symposium, as well as an oral and six poster presentations * Presentations will include...

2024-01-18 02:20 1608

Seal Storage Technology Bolsters Compliance with HIPAA-Compliant Blockchain-Based Data Storage

TORONTO, Jan. 17, 2024 /PRNewswire/ -- - Seal Storage Technology, a leading provider of blockchain-powered cloud storage, is now able to enter Business Associate Agreements (BAAs) to handle protected health information (PHI) with its completion of HIPAA certification. Seal's compliance with HIPAA...

2024-01-17 23:45 1339

Seno Medical Earns Frost & Sullivan's 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology

Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. SAN ANTONIO, Jan. 17, 2024 /PRNewswire/ -- Frost & Sullivan recently recognizedSeno Medical with the 2023 US Enabling Technology Leadersh...

2024-01-17 23:00 1396

Shaping International Economics and Ethical Dialogues Through the Leadership of Cheah Chyuan Yong

KUALA LUMPUR, Malaysia, Jan. 17, 2024 /PRNewswire/ -- Under the visionary leadership ofCheah Chyuan Yong, the International Strategy Institute (ISI) proudly declares the successful conclusion of two groundbreaking global conferences: the 12th World Chinese Economic Forum (WCEF) and the World Ant...

2024-01-17 21:41 1705

Shaping International Economics and Ethical Dialogues Through the Leadership of Cheah Chyuan Yong

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansionshowed clinical benefit including confirmed responses at higher, more frequent and repeat doses of the anti-CTLA-4 therapy - - Preliminary survival analysis of ADG126 10 mg/kg do...

2024-01-17 20:00 2408

Envision Energy Announces Collaboration with Five Global Healthcare Leaders to Unlock Renewable Energy in Davos

Envision Energy signed a three-year renewable energy supply agreement with AstraZeneca, Lonza, Novartis, Novo Nordisk and Roche, to offer around 200 gigawatt-hours (GWh) of green power annually from 2024, resulting in annual carbon dioxide equivalent savings of approximately 120,000 tons. ...

2024-01-17 14:50 1607

SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases inAustralia each year and estimated direct and indirect costs of $700 million and $4 billion respectively SEATTLE and BRISBANE, Australia, Jan. 17, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...

2024-01-17 06:00 1636

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this...

2024-01-16 21:00 1256

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...

2024-01-16 21:00 1427

HOPE FOR FEMALE CANCER PATIENTS TO PRESERVE FERTILITY THROUGH OVARIAN TISSUE CRYOPRESERVATION AT SUNFERT

Sunfert International Fertility Centre is the First Private Oncofertility Hub in Malaysia KUALA LUMPUR, Malaysia, Jan. 16, 2024 /PRNewswire/ -- Reproductive medicine has achieved groundbreaking milestones, andMalaysia is one of the countries that is sought after by couples near and far to realis...

2024-01-16 18:14 1434